Betaine anhydrous in homocystinuria: results from the RoCH registry

Abstract Background The Registry of Adult and Paediatric Patients Treated with Cystadane® – Homocystinuria (RoCH) is a non-interventional, observational, multi-centre, post-authorization safety study that aimed to identify safety of betaine anhydrous (Cystadane®) in the treatment of patients with in...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Vassili Valayannopoulos, Manuel Schiff, Nathalie Guffon, Yann Nadjar, Angels García-Cazorla, Mercedes Martinez-Pardo Casanova, Aline Cano, Maria L. Couce, Jaime Dalmau, Luis Peña-Quintana, Vincent Rigalleau, Guy Touati, Luis Aldamiz-Echevarria, Pascal Cathebras, Didier Eyer, Dominique Brunet, Léna Damaj, Dries Dobbelaere, Claire Gay, Sylvie Hiéronimus, Virginie Levrat, François Maillot
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2019-03-01
Серии:Orphanet Journal of Rare Diseases
Предметы:
Betaine anhydrous
Efficacy
Homocystinuria
RoCH registry
Safety
Online-ссылка:http://link.springer.com/article/10.1186/s13023-019-1036-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы